In HepAD38 cells, Cyclocytidine at concentrations over 20 µM produced over 50% cytotoxicity after 2d treatment in an MTT cell viability assay. At 20 µM, Cyclocytidine-treated HepAD38 cells exhibited about 50% cell viability after 4 days treatment, as measured by an MTT assay. [1]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Cytotoxicity in HepAD38 Cells
Cell-based study · HepAD38 cells [1]
HepAD38 cells treated with Cyclocytidine at concentrations over 20 µM exhibited over 50% cytotoxicity after 2d treatment, as measured by the MTT cell viability assay.
Literature-Reported Treatment Conditions
- Treatment concentration
- concentrations over the 20 µM
- Exposure duration
- 2d treatment
- Method
- cultured in 6-cm culture dish with different amounts of cyclocytidine HCl
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Cyclocytidine
Evidence for Cyclocytidine as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A11683; no salt equivalence, dose conversion or lot validation.
Material and Methods > Cell culture and cyclocytidine HCl treatment (S3); Material and Methods > MTT assay (S6, S7, S10); Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S27)
MTT cell viability assay: MTT cell viability assay; comparator: The same volume of dimethyl sulfoxide (DMSO) was added to cells as a mock treatment. — Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S27)
Cell Viability in HepAD38 Cells
Cell-based study · HepAD38 cells [1]
HepAD38 cells treated with Cyclocytidine at 20 µM exhibited about 50% cell viability after 4 days treatment, as measured by an MTT assay.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20 µM
- Exposure duration
- day 2 and day 4
- Method
- cultured in 6-cm culture dish with different amounts of cyclocytidine HCl
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Cyclocytidine
Evidence for Cyclocytidine as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A11683; no salt equivalence, dose conversion or lot validation.
Material and Methods > Cell culture and cyclocytidine HCl treatment (S3); Material and Methods > MTT assay (S6, S7, S10); Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S29, S30); Figure 1 legend (S41)
cell viability was measured using a MTT assay: cell viability was measured using a MTT assay; comparator: The same volume of dimethyl sulfoxide (DMSO) was added to cells as a mock treatment. — Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S30); Figure 1 legend (S41)